Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 270-273

  Shih, Karin K ^a   Zhou, Qin C ^a   Aghajanian, Carol ^a   Huh, Jae ^a   Soslow, Robert A ^a   Morgan, Jessica C ^a   Iasonos, Alexia ^a   Chi, Dennis S ^a   Barakat, Richard R ^a   Abu Rustum, Nadeem R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Advanced stage; Chemotherapy; Ovarian borderline tumor; Recurrence

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MITOXANTRONE; PACLITAXEL;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLA; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; OMENTUM; OVARY SEROUS BORDERLINE TUMOR; OVARY TUMOR; PELVIS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; ADJUVANT CHEMOTHERAPY; CYSTADENOCARCINOMA, SEROUS; DISEASE FREE SURVIVAL; MIDDLE AGED; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77957750586     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.07.019     Document Type: Article

References (28)

1. R.R. Barakat Borderline tumors of the ovary Obstet Gynecol Clin North Am 21 1994 93 105
2. E.G. Silva, R.J. Kurman, and P. Russell Scully RE.Symposium: ovarian tumors of borderline malignancy Int J Gynecol Pathol 15 1996 281 302 (Pubitemid 26314055)
3. W.R. Hart Borderline epithelial tumors of the ovary Mod Pathol 18 Suppl 2 2005 S33 S50
4. R.J. Kurman, J.D. Seidman, and I.M. Shih Serous borderline tumours of the ovary Histopathology 47 2005 310 315
5. J.H. Eichhorn, D.A. Bell, R.H. Young, and R.E. Scully Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns Am J Surg Pathol 23 1999 397 409
6. J.D. Seidman, and R.J. Kurman Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators Hum Pathol 31 2000 539 557
7. R.E. Bristow, D.R. Gossett, D.R. Shook, M.L. Zahurak, R.S. Tomacruz, and D.K. Armstrong Micropapillary serous ovarian carcinoma: surgical management and clinical outcome Gynecol Oncol 86 2002 163 170
8. M.T. Deavers, D.M. Gershenson, G. Tortolero-Luna, A. Malpica, K.H. Lu, and E.G. Silva Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases Am J Surg Pathol 26 2002 1129 1141
9. J. Prat, and M. De Nictolis Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion Am J Surg Pathol 26 2002 1111 1128
10. P. Morice, S. Camatte, A. Rey, D. Atallah, C. Lhommé, and P. Pautier Prognostic factors for patients with advanced stage serous borderline tumours of the ovary Ann Oncol 14 2003 592 598
11. G. Zanetta, S. Rota, S. Chiari, C. Bonazzi, G. Bratina, and C. Mangioni Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study J Clin Oncol 19 2001 2658 2664
12. J. Kaern, C.G. Tropé, G.B. Kristensen, V.M. Abeler, and E.O. Pettersen DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary Int J Gynecol Cancer 3 1993 349 358
13. T.A. Longacre, J.K. McKenney, H.D. Tazelaar, R.L. Kempson, and M.R. Hendrickson Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up Am J Surg Pathol 29 2005 707 723
14. I. Cadron, K. Leunen, T. Van Gorp, F. Amant, P. Neven, and I. Vergote Management of borderline ovarian neoplasms J Clin Oncol 25 2007 2928 2937
15. M.G. Fort, V.K. Pierce, P.E. Saigo, W.J. Hoskins, and J.L. Lewis Jr Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential Gynecol Oncol 32 1989 269 272
16. R.R. Barakat, I. Benjamin, J.L. Lewis Jr, P.E. Saigo, J.P. Curtin, and W.J. Hoskins Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential Gynecol Oncol 59 1995 390 393
17. G.P. Sutton, B.N. Bundy, G.A. Omura, E.L. Yordan, J.B. Beecham, and T. Bonfiglio Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study) Gynecol Oncol 41 1991 230 233
18. C. Tropé, J. Kaern, I.B. Vergote, G. Kristensen, and V. Abeler Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors Gynecol Oncol 51 1993 236 243
19. J.L. Benedet, H. Bender, H. Jones III, H.Y. Ngan, and S. Pecorelli FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int J Gynaecol Obstet 70 2000 209 262
20. G.J. Rustin, A.E. Nelstrop, S.M. Bentzen, M.J. Piccart, and K. Bertelsen Use of tumour markers in monitoring the course of ovarian cancer Ann Oncol 10 Suppl 1 1999 21 27
21. D.M. Gershenson, E.G. Silva, L. Levy, T.W. Burke, J.K. Wolf, and C. Tornos Ovarian serous borderline tumors with invasive peritoneal implants Cancer 82 1998 1096 1103 (Pubitemid 28136523)
22. D.M. Gershenson, E.G. Silva, G. Tortolero-Luna, C. Levenback, M. Morris, and C. Tornos Serous borderline tumors of the ovary with noninvasive peritoneal implants Cancer 83 1998 2157 2163 (Pubitemid 28525397)
23. J.D. Seidman, and R.J. Kurman Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors) Cancer 95 2002 675 676
24. S. Camatte, P. Morice, P. Pautier, D. Atallah, P. Duvillard, and D. Castaigne Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary BJOG 109 2002 376 380
25. A. Fortin, P. Morice, A. Thoury, S. Camatte, C. Dhainaut, and P. Madelenat Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study Fertil Steril 87 2007 591 596
26. P. Morice, S. Camatte, J. El Hassan, P. Pautier, P. Duvillard, and D. Castaigne Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors Fertil Steril 75 2001 92 96
27. X. Deffieux, P. Morice, S. Camatte, V. Fourchotte, P. Duvillard, and D. Castaigne Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants Gynecol Oncol 97 2005 84 89
28. E.G. Silva, D.M. Gershenson, A. Malpica, and M. Deavers The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent Am J Surg Pathol 30 2006 1367 1371